Skip to main content
    S

    Stryker Corporation (SYK)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $310.67
    +1.03 (+0.33%)

    Market Cap: $117.88B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Stryker Corporation (SYK) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Stryker (SYK) trades at 21.8x trailing earnings and 4.5x sales. Its P/E of 21.8x is below its 5-year median of 28.7x. Its forward P/E is 19.1x. The median P/E across 9 similar companies is 18.0x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 14.1% higher over the next year. Its free cash flow yield is 3.9%.

    MultipleValue
    P/E (trailing)21.8x
    Forward P/E19.1x
    Price to sales4.5x
    Price to book5.1x
    EV/EBITDA17.7x
    Price to FCF26.0x
    EV/FCF28.5x
    PEG1.5
    FCF yield3.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 18.7% below 26.8x, its P/S is 15.1% below 5.3x and its P/B is 19.0% below 6.3x.

    MultipleCurrent5-year median10-year median
    P/E21.8x28.7x26.8x
    P/S4.5x5.7x5.3x
    P/B5.1x6.3x6.3x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 20.7x in 2016 to 33.0x in 2020.

    Year endPriceP/EP/SP/B
    2025$351.4725.8x5.4x6.1x
    2024$360.0529.5x6.1x6.7x
    2023$299.4628.3x5.6x6.2x
    2022$244.4926.2x5.0x5.6x
    2021$267.4229.4x5.9x6.9x
    2020$245.0433.0x6.4x7.1x
    2019$209.9425.4x5.3x6.2x
    2018$156.7521.4x4.3x5.1x
    2017$154.8423.9x4.7x5.9x
    2016$119.8120.7x4.0x4.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SYK

    What is SYK's forward P/E ratio?

    Stryker has a forward P/E ratio of 19.1x.

    Is SYK stock overvalued?

    GNG's valuation label for SYK is Undervalued. Its P/E of 21.8x compares with a median of 18.0x across 9 similar companies.

    What is SYK's price to sales ratio?

    Stryker has a price to sales ratio of 4.5x.

    What is Stryker's average P/E ratio over 5 years?

    Stryker's median P/E over the last 5 years is 28.7x, from 60 month-end values through Oct 2026.

    What is SYK's PEG ratio?

    Stryker has a PEG ratio of 1.5.